MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS

Federica Barutta1, Beatrice Corbetta2, Stefania Bellini2

  • 1Diabetic Nephropathy Laboratory, Department of Medical Sciences, University of Turin, C/so Dogliotti 14, 10126, Turin, Italy. federica.barutta@unito.it.

Abstract

Insights

Lower serum levels of microRNA-146a-5p (miR-146a-5p) are linked to increased risk of type 1 diabetes complications. This suggests miR-146a-5p may serve as a novel biomarker for diabetic complications, particularly cardiovascular disease and retinopathy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • MicroRNA-146a-5p (miR-146a-5p) is a crucial regulator of inflammation.
  • Altered miR-146a-5p expression is observed in diabetic complication target organs, and its deficiency is implicated in pathogenesis.
  • This study investigates the association between serum miR-146a-5p levels and micro/macrovascular complications in type 1 diabetes (DM1).

Purpose of the Study:

  • To determine if serum miR-146a-5p levels are independently associated with micro/macrovascular complications in type 1 diabetes (DM1).

Main Methods:

  • A nested case-control study involving 447 DM1 patients from the EURODIAB PCS was conducted.
  • Serum miR-146a-5p levels were quantified using qPCR and normalized with U6 snRNA and Cel-miR-39 spike.
  • Logistic regression analysis was employed to assess the association between miR-146a-5p levels and diabetes complications.

Main Results:

  • Patients with diabetes complications (cases) exhibited significantly lower serum miR-146a-5p levels compared to controls.
  • Higher miR-146a-5p levels (upper quartile) were inversely associated with a reduced odds ratio for all diabetes complications (OR 0.34).
  • This inverse association was particularly noted for cardiovascular diseases (CVD) (OR 0.31) and diabetic retinopathy (OR 0.40), independent of other clinical factors.

Conclusions:

  • Serum miR-146a-5p is inversely and independently associated with chronic complications of type 1 diabetes, including CVD and retinopathy.
  • These findings suggest that miR-146a-5p may represent a novel candidate biomarker for predicting and monitoring diabetic complications.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.8K